Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Monique Dail"'
Autor:
David Sharon, Paul Jung, Yan Sun, Weiguo Feng, Ziping Yang, Valerie Robinson, Diya Mitra, Wei Liu, Pingping Zheng, Tami Uziel, Lloyd Lam, Mark Minden, Jeremy Ross, Wellington Mendes, Jalaja Potluri, Andrew Wei, Marina Konopleva, Monique Dail, Brenda Chyla, Pk Epling-Burnette
Publikováno v:
HemaSphere, Vol 7, p e7041879 (2023)
Externí odkaz:
https://doaj.org/article/367ff993d461456dabd8a416bda0598b
Autor:
Marina Konopleva, Courtney D. Dinardo, Yan Sun, Sanam Loghavi, Paul Jung, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea
Publikováno v:
HemaSphere, Vol 7, p e160928c (2023)
Externí odkaz:
https://doaj.org/article/feb327d309ba482292b12a9757915013
Autor:
Hussein A. Abbas, Vakul Mohanty, Ruiping Wang, Yuefan Huang, Shaoheng Liang, Feng Wang, Jianhua Zhang, Yihua Qiu, Chenyue W. Hu, Amina A. Qutub, Monique Dail, Christopher R. Bolen, Naval Daver, Marina Konopleva, Andrew Futreal, Ken Chen, Linghua Wang, Steven M. Kornblau
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Acute myeloid leukemia (AML) is a heterogeneous disease with variable responses to therapy. Cytogenetic and genomic features are used to classify AML patients into prognostic and treatment groups. However, these molecular characteristics harbor signi
Externí odkaz:
https://doaj.org/article/3fa0453989f444be9cf6786abeda8ff8
Autor:
Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha Mary Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath, Elisabeth A. Lasater
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
FLT3 internal tandem duplication (FLT3-ITD) mutations account for ~25% of adult acute myeloid leukemia cases and are associated with poor prognosis. Venetoclax, a selective BCL-2 inhibitor, has limited monotherapy activity in relapsed/refractory acut
Externí odkaz:
https://doaj.org/article/2c93cdcda4114fa79bedeef57cf35957
Autor:
Lina Han, Qi Zhang, Monique Dail, Ce Shi, Antonio Cavazos, Vivian R. Ruvolo, Yang Zhao, Eugene Kim, Mohamed Rahmani, Duncan H. Mak, Sha S. Jin, Jun Chen, Darren C. Phillips, Paul Bottecelli Koller, Rodrigo Jacamo, Jared K. Burks, Courtney DiNardo, Naval Daver, Elias Jabbour, Jing Wang, Hagop M. Kantarjian, Michael Andreeff, Steven Grant, Joel D. Leverson, Deepak Sampath, Marina Konopleva
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
The pathogenesis of acute myeloid leukemia (AML) involves serial acquisition of mutations controlling several cellular processes, requiring combination therapies affecting key downstream survival nodes in order to treat the disease effectively. The B
Externí odkaz:
https://doaj.org/article/e0012766be134ddfaa79a50aa20f66b5
Autor:
Benjamin J Huang, Anica M Wandler, Lauren K Meyer, Monique Dail, Anneleen Daemen, Deepak Sampath, Qing Li, Xinyue Wang, Jasmine C Wong, Joy Nakitandwe, James R Downing, Jinghui Zhang, Barry S Taylor, Kevin Shannon
Publikováno v:
PLoS Genetics, Vol 15, Iss 6, p e1008168 (2019)
The lack of predictive preclinical models is a fundamental barrier to translating knowledge about the molecular pathogenesis of cancer into improved therapies. Insertional mutagenesis (IM) in mice is a robust strategy for generating malignancies that
Externí odkaz:
https://doaj.org/article/faa44ed874b34b81857476a8f891244d
Autor:
Amit J Sabnis, Laurene S Cheung, Monique Dail, Hio Chung Kang, Marianne Santaguida, Michelle L Hermiston, Emmanuelle Passegué, Kevin Shannon, Benjamin S Braun
Publikováno v:
PLoS Biology, Vol 7, Iss 3, p e59 (2009)
How oncogenes modulate the self-renewal properties of cancer-initiating cells is incompletely understood. Activating KRAS and NRAS mutations are among the most common oncogenic lesions detected in human cancer, and occur in myeloproliferative disorde
Externí odkaz:
https://doaj.org/article/55fb03daa2bc4376b9d210391fe4c84f
Autor:
Naval Daver, Alexander E. Perl, Joseph Maly, Mark Levis, Ellen Ritchie, Mark Litzow, James McCloskey, Catherine C. Smith, Gary Schiller, Terrence Bradley, Ramon V. Tiu, Kiran Naqvi, Monique Dail, Deanna Brackman, Satya Siddani, Jing Wang, Brenda Chyla, Paul Lee, Jessica K. Altman
Publikováno v:
Journal of Clinical Oncology. 40:4048-4059
PURPOSE The FMS-related tyrosine kinase 3 (FLT3) inhibitor gilteritinib is standard therapy for relapsed/refractory FLT3-mutated ( FLT3 mut) acute myeloid leukemia (AML) but seldom reduces FLT3 mut burden or induces sustained efficacy. Gilteritinib c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2d971be25ac6f7504f1727fdeb5b92e
https://doi.org/10.1200/jco.22.00602
https://doi.org/10.1200/jco.22.00602
Autor:
Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Brian A. Jonas, Vinod A. Pullarkat, Michael J. Thirman, Christian Recher, Andre C. Schuh, Sunil Babu, Monique Dail, Grace Ku, Yan Sun, Jalaja Potluri, Brenda Chyla, Daniel A. Pollyea
Publikováno v:
Blood. 140:1441-1444
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ebe2cbb454c4b64823569b44defe6d8
https://doi.org/10.1182/blood-2022-169509
https://doi.org/10.1182/blood-2022-169509
Autor:
Courtney D. DiNardo, Brenda Chyla, Jalaja Potluri, Yan Sun, Monique Dail, Andre C. Schuh, Sunil Babu, Christian Recher, Brian A. Jonas, Vinod Pullarkat, Andrew H. Wei, Keith W. Pratz, Daniel A. Pollyea
Supplementary Table from Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b896ac5aad0d8e9771e4a4a92901640
https://doi.org/10.1158/1078-0432.22488521.v1
https://doi.org/10.1158/1078-0432.22488521.v1
